WordNet

a substance that exerts some force or effect
a businessman who buys or sells for another in exchange for a commission (同)factor, broker
any agent or representative of a federal agency or bureau (同)federal agent
a representative who acts on behalf of other persons or organizations
an active and efficient cause; capable of producing a certain effect; "their research uncovered new disease agents"
the 1st letter of the Roman alphabet (同)a
the blood group whose red cells carry the A antigen (同)type_A, group A

PrepTutorEJDIC

『代理人』;周旋人 / 働き(作用)を起こすもの;作用物,薬剤 / (政府機関,特にFBI,CIAなどの)部員,機関員
Anglo-Saxon
answer / ampere

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. アスピリン：リウマチ性疾患における作用機序、主な毒性、および使用 aspirin mechanism of action major toxicities and use in rheumatic diseases
2. アスピリンの無効および耐性 nonresponse and resistance to aspirin
3. 血液透析用の人工血管のメンテナンスと閉塞予防の概要 overview of hemodialysis arteriovenous graft maintenance and thrombosis prevention
4. アテローム動脈硬化性心血管疾患の二次予防に使用するアスピリン aspirin for the secondary prevention of atherosclerotic cardiovascular disease
5. 非ステロイド性抗炎症剤（NSAIDs）（アスピリンを含む）：胃十二指腸障害の一次予防 nsaids including aspirin primary prevention of gastroduodenal toxicity

English Journal

Japanese Journal

第45回日本腹部救急医学会総会会長講演 : 潰瘍性大腸炎

日本腹部救急医学会雑誌 = Journal of abdominal emergency medicine 29(7), 945-950, 2009-11-30
NAID 10026325916

直腸炎型潰瘍性大腸炎と強く関連する非びまん性胃病変の1例

日本消化器病學會雜誌 = The Japanese journal of gastro-enterology 106(1), 61-68, 2009-01-05
NAID 10024850257

Related Links

Fact Sheet - Crohn's | Colitis | IBD | Crohn’s & Colitis Foundation

Aminosalicylates are compounds that contain 5-aminosalicylic acid (5-ASA) and reduce inflammation in the lining of the intestine. Some forms may also reduce joint inflammation. While any medication has potential risks (see ...

5-Aminosalicylic Acid Derivatives Drug Class Review

7 Table 2. Labeled indications for the 5-Aminosalicylic Acid Derivatives Agents Treatment of mild-moderate UC Adjunctive therapy in severe UC Maintenance of remission of UC Maintenance of remission in patients intolerant to